Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia: a Prospective 12 Months Study

NCT07673302 is registered in ClinicalTrials.gov with Riphah International University as lead sponsor.

NCT NCT07673302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07673302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia: a Prospective 12 Months Study
Lead sponsor
Riphah International University
Phase
Not applicable
Overall status
Recruiting
Start date
June 20, 2026
Completion date
June 19, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia